SCHEMBL2412704

SCHEMBL2412704

Cc1ccc(-c2cccc(O[C@H]3SC[C@@H](O)[C@H](O)[C@H]3O)c2)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.40
WDR77 Q9BQA1 1/20 0.40
ABL1 P00519 1/20 0.38
BCR P11274 1/20 0.38
PIK3CD O00329 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33
PI4KA P42356 1/20 0.33
PIK3CG P48736 1/20 0.33
PI4KB Q9UBF8 1/20 0.33
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ACHE P22303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2412695 1.00 PRMT5 (0.40) PRMT5WDR77ABL1BCRPIK3CD
SCHEMBL2409698 0.87 HSD17B1 (0.33) ADORA3FYNEGLN1HSD17B1HSD17B2
SCHEMBL2409694 0.87 HSD17B1 (0.33) ADORA3FYNEGLN1HSD17B1HSD17B2
SCHEMBL2411104 0.86 HSD17B1 (0.49) PIK3CDPIK3CAPIK3CBPI4KAPIK3CG
SCHEMBL2411109 0.86 HSD17B1 (0.49) PIK3CDPIK3CAPIK3CBPI4KAPIK3CG
SCHEMBL2413305 0.86 NPC1 (0.38) PIK3CDADORA3NAAA
SCHEMBL2417948 0.86 GRM5 (0.36) ADORA3
SCHEMBL2413310 0.86 NPC1 (0.38) PIK3CDADORA3NAAA
SCHEMBL2417950 0.86 GRM5 (0.36) ADORA3
SCHEMBL2408850 0.86 WNT3A (0.38) ABL1PIK3CBCYP3A4ADORA3WNT3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8013010-B2 5-thioxylopyranose compounds LABORATOIRES FOURNIER S.A. (FR) 2011-09-06 US disclosed
US-20090186840-A1 5-Thioxylopyranose Compounds LABORATOIRES FOURNIER S.A (FR) 2009-07-23 US disclosed
EP-2066681-A1 NEW DERIVATIVES OF 5-THIOXILOPYRANOSE LABORATOIRES FOURNIER SA (FR) 2009-06-10 EP disclosed
WO-2008037923-A1 NEW DERIVATIVES OF 5-THIOXILOPYRANOSE LABORATOIRES FOURNIER S.A. (FR) 2008-04-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090186840-A1 5-Thioxylopyranose Compounds TPMT, PNPO, CYP3A5 PRMT5 961/4885WDR77 3751/4885ABL1 2708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.